Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
In rodent and human brains, the small GTP-binding protein Rhes is highly expressed in virtually all dopaminoceptive striatal GABAergic medium spiny neurons, as well as in large aspiny cholinergic interneurons, where it is thought to modulate dopamine-dependent signaling. Consistent with this knowled...
Main Authors: | Francesco Napolitano, Emily Booth Warren, Sara Migliarini, Daniela Punzo, Francesco Errico, Qin Li, Marie-Laure Thiolat, Angelo Luigi Vescovi, Paolo Calabresi, Erwan Bezard, Micaela Morelli, Christine Konradi, Massimo Pasqualetti, Alessandro Usiello |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5526584?pdf=render |
Similar Items
-
Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age
by: Giulia Costa, et al.
Published: (2018-05-01) -
Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons’ Degeneration: Link to Parkinson’s Disease
by: Marcello Serra, et al.
Published: (2021-05-01) -
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons
by: Giuseppe Sciamanna, et al.
Published: (2015-06-01) -
Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age
by: Giulia Costa, et al.
Published: (2019-03-01) -
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia
by: Alberto Brugnoli, et al.
Published: (2016-01-01)